Viewing Study NCT02976857


Ignite Creation Date: 2025-12-24 @ 6:44 PM
Ignite Modification Date: 2026-06-03 @ 5:47 PM
Study NCT ID: NCT02976857
Status: COMPLETED
Last Update Posted: 2019-01-17
First Post: 2016-11-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study Evaluating Safety and Efficacy of C-CAR011 Treatment in DLBCL Subjects
Sponsor: Shanghai AbelZeta Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory Diffuse Large B-Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None refractory diffuse large B-cell lymphoma View
None anti-CD19 chimeric antigen receptor T-cell View